Kairos Biomedical Patents – Insights and Stats (Updated 2023)

Kairos Biomedical has a total of 4 patents globally, out of which no patent have been granted. Of these 4 patents, more than 25% patents are active. The United States of America is where Kairos Biomedical has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Kairos Biomedical.

Kairos Biomedical was founded in 2017. Kairos Biomedical is a company in the medical field that finds, creates, and sells products to boost the immune system and treat diseases.

Do read about some of the most popular patents of Kairos Biomedical which have been covered by us in this article and also you can find Kairos Biomedical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kairos Biomedical patent portfolio.

How many patents does Kairos Biomedical have?

Kairos Biomedical has a total of 4 patents globally. These patents belong to 2 unique patent families. Out of 4 patents, 1 patent is active.

How Many Patents did Kairos Biomedical File Every Year?

The Kairos Biomedical filled 4 patents correspondingly the filling years are 2018 and 2019.

Year of Patents Filing or GrantKairos Biomedical Applications FiledKairos Biomedical Patents Granted
20192
20182

How many Kairos Biomedical patents are Alive/Dead?

Kairos Biomedical Patent Portfolio

 How Many Patents did Kairos Biomedical File in Different Countries?

Kairos Biomedical filled all their patents in United States of America.

Where are Research Centers of Kairos Biomedical Patents Located?

The Research Center of Kairos Biomedical Patents is the United States of America.

What Percentage of Kairos Biomedical US Patent Applications were Granted?

Kairos Biomedical (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these no patent has been granted leading to a grant rate of 0%.

Below are the key stats of Kairos Biomedical patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Kairos Biomedical?

Law FirmTotal ApplicationsSuccess Rate
Knobbe Martens Olson & Bear Llp10%

List of Kairos Biomedical Patents

Kairos Biomedical PatentTitle
US20210236569A1Bioactive Fungal Compounds Produced By Solid-State Fermentation
US20200197513A1Nutraceutical Blends
WO2019209706A3Bioactive Fungal Compounds Produced By Solid-State Fermentation
WO2018209139A1Nutraceutical Blends

What are Kairos Biomedical key innovation segments?

What Technologies are Covered by Kairos Biomedical?

The chart below distributes patents filed by Kairos Biomedical in different countries on the basis of the technology protected in patents. It also represents the markets where Kairos Biomedical thinks it’s important to protect particular technology inventions.

R&D Focus: How has Kairos Biomedical search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Kairos Biomedical?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.